Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    A
  • Alendronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formTrihydrate

    CAS No.121268-17-5

    View more
  • Apremilast

    StatusPipeline

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm B

    CAS No.608141-41-9

    View more
  • B
  • Baclofen

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm B

    CAS No.1134-47-0

    View more
  • E
  • Etodolac

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formCrystalline racemate, none

    CAS No.41340-25-4

    View more
  • I
  • Ibandronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formMonohydrate Form B

    CAS No.138926-19-9

    View more
  • R
  • Risedronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm A

    CAS No.329003-65-8

    View more
  • Z
  • Zoledronic acid

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formMonohydrate

    CAS No.165800-06-6

    View more